Latest Healthcare Research Reports

Tag: controlled release drug delivery market forecast

  • Industry Forecast: Controlled Release Drug Delivery Market to Generate $117.24 Billion Revenue by 2029

    Industry Forecast: Controlled Release Drug Delivery Market to Generate $117.24 Billion Revenue by 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Current and Projected Market Size of the Controlled Release Drug Delivery Industry?

    The market for controlled release drug delivery has experienced rapid expansion in recent times. The market which was worth $65.44 billion in 2024 is projected to escalate to $72.34 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this growth during the historic period include advancements in drug delivery systems, the development of early polymer-based formulations, the introduction of microencapsulation methods, the rise of transdermal delivery, regular approvals from authorities, and increasing standardization.

    Over the following years, a swift expansion is anticipated in the controlled release drug delivery market’s size, projected to reach “$117.24 billion in 2029, with a compound annual growth rate (CAGR) of 12.8%. The upcoming growth can be linked to the shift towards personalized medicine, the incorporation of technology for patient convenience, the proliferation of biologics and biosimilars, market spread in developing regions, and advances in polymer science. The major anticipated trends in this growth period involve biodegradable and biocompatible materials, progress in nanotechnology, individualized medicine and targeted therapies, improvements in implantable devices, and groundbreaking encapsulation techniques.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp

    #Which Factors Are Currently Driving The Growth Of The Controlled Release Drug Delivery Market?

    The escalating occurrence of enduring ailments is anticipated to push the expansion of the controlled release drug delivery market. Noncommunicable or chronic diseases include conditions such as cancer, diabetes, and heart disease, which can continue for more than a year and often necessitate ongoing medical treatment while inhibiting day-to-day tasks. Controlled-release drug delivery proves crucial for managing chronic conditions. For individuals dealing with prolonged illnesses or those living in areas with restricted healthcare resources, drug delivery methods facilitating extended medicinal release are vital. For example, a September 2022 report by the World Health Organization (WHO), a Swiss institutional expert in health, revealed that annually, chronic diseases claim 41 million lives, accounting for 74 percent of global deaths. Before reaching the age of 70, 17 million people succumb to chronic diseases, and approximately 77 percent of chronic disease-related deaths occur in economically less abundant countries. These figures are predicted to increase in the future, thus the escalating incidence of chronic diseases is fueling the expansion of the controlled release drug delivery market.

    How Is The Global Controlled Release Drug Delivery Market Structured In Terms Of Segments?

    The controlled release drug delivery market covered in this report is segmented –

    1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies

    2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,

    3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications

    4) By End User: Hospitals, Clinics, Personal, Research, Other End Users

    Subsegments:

    1) By Wurster Technique: Spray Coating, Fluid Bed Coating

    2) By Coacervation: Simple Coacervation, Complex Coacervation

    3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation

    4) By Implants: Biodegradable Implants, Non-Biodegradable Implants

    5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems

    6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes

    7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems

    What Notable Trends Are Shaping The Direction Of The Controlled Release Drug Delivery Market?

    The proliferation of technological improvement is increasingly becoming a prominent trend within the controlled-release drug delivery market. Major players in this space are leveraging new innovations in technology to maintain market dominance. For example, in March 2022, Germany’s Evonik Industries AG introduced UDRATEC SoluFlow to the market, a cutting-edge microparticle technology crafted to enhance the solubility of active pharmaceutical ingredients within oral medicinal formulas. This innovative technique surpasses the solubility limitations of conventional production techniques. The addition of UDRATEC SoluFlow to Evonik Health Care’s suite of offerings, which encompass oral excipients such as EUDRAGIT Funcional polymers, and also a unique ready-to-load capsules like EUDRACAPTM, along with other offerings, highlights the company’s commitment to boost medication performance.

    Who Are The Main Participants Shaping The Controlled Release Drug Delivery Market Landscape?

    Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

    Which Region Currently Holds The Largest Share In The Controlled Release Drug Delivery Market?

    North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=9930&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Industry Forecast: Controlled Release Drug Delivery Market to Generate $117.24 Billion Revenue by 2029

    Industry Forecast: Controlled Release Drug Delivery Market to Generate $117.24 Billion Revenue by 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Current and Projected Market Size of the Controlled Release Drug Delivery Industry?

    Over the most recent years, the controlled release drug delivery market has seen a quick expansion. The market size is set to grow from $65.44 billion in 2024 to an estimated $72.34 billion in 2025, evidencing a compound annual growth rate (CAGR) of 10.5%. The historic growth of the market can be credited to factors such as the inception of innovative drug delivery systems, the introduction of early polymer-based formulations, the usage of microencapsulation techniques, the arrival of transdermal delivery, in addition to regulatory approvals and standardization.

    Anticipated to witness significant expansion in the coming years, the controlled release drug delivery market’s valuation is predicted to reach $117.24 billion by 2029, with a considerable compound annual growth rate (CAGR) of 12.8%. This predicted growth during the forecast period can be ascribed to shifts towards customized medicine, the incorporation of advanced technology for improved patient comfort, the rise in biologics and biosimilars, market development in burgeoning regions, and advancements in the field of polymer science. The market is also likely to be shaped by trends such as the use of biodegradable and biocompatible materials, advancements in nanotechnology, personalized medicines and targeted therapies, advances in implantable medical devices, and innovations in encapsulation methodologies.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp

    #Which Factors Are Currently Driving The Growth Of The Controlled Release Drug Delivery Market?

    The proliferation of chronic diseases is anticipated to drive the controlled release drug delivery market’s expansion. Chronic diseases, also termed as noncommunicable diseases, comprise conditions such as heart disease, cancer, and diabetes diseases that last over a year and necessitate continuous medical care or impose limitations on daily activities, or both. Administering controlled-release drug delivery is imperative for chronic disease treatment. It is particularly significant for those living with chronic disorders that demand years of treatment or for individuals residing in areas with restricted resources and healthcare accessibility. Drug delivery systems enabling extended medication release are indispensable in such cases. For example, as per a September 2022 report from the World Health Organization (WHO), a health-focused agency based in Switzerland, chronic diseases account for the annual death of 41 million people, which constitutes 74% of the global death toll. Seventeen million people succumb to chronic diseases before reaching the age of 70. Furthermore, 77% of chronic disease-related deaths occur in low- and middle-income countries. These figures are projected to surge in the future. Consequently, the escalating occurrence of chronic diseases is fuelling the controlled release drug delivery market growth.

    How Is The Global Controlled Release Drug Delivery Market Structured In Terms Of Segments?

    The controlled release drug delivery market covered in this report is segmented –

    1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies

    2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,

    3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications

    4) By End User: Hospitals, Clinics, Personal, Research, Other End Users

    Subsegments:

    1) By Wurster Technique: Spray Coating, Fluid Bed Coating

    2) By Coacervation: Simple Coacervation, Complex Coacervation

    3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation

    4) By Implants: Biodegradable Implants, Non-Biodegradable Implants

    5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems

    6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes

    7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems

    What Trends Are Currently Influencing Growth In The Controlled Release Drug Delivery Market?

    The controlled-release drug delivery market is seeing a rise in technological innovation as a major trend. To secure their market positions, key companies in this sector are increasingly adopting novel technologies. In March 2022, for example, Evonik Industries AG, a pharmaceutical company based in Germany, introduced UDRATEC SoluFlow. This new microparticle technology enhances the solubility of active ingredients in oral drug formulations, offering a solution to solubility issues that conventional production methods fail to solve. EUDRATEC SoluFlow is an addition to the extensive portfolio of oral drug delivery solutions offered by Evonik Health Care, which includes oral excipients like EUDRAGIT functional polymers, ready-to-fill functional capsules such as EUDRACAPTM, and various other technologies and services aimed at enhancing drug performance.

    Who Are The Main Participants Shaping The Controlled Release Drug Delivery Market Landscape?

    Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

    Which Region Currently Holds The Largest Share In The Controlled Release Drug Delivery Market?

    North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=9930&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Controlled Release Drug Delivery Industry Growth Expected to Reach $119.41 Billion by 2029 at a CAGR of 13.1% | Segmentation and Growth Opportunities

    Controlled Release Drug Delivery Industry Growth Expected to Reach $119.41 Billion by 2029 at a CAGR of 13.1% | Segmentation and Growth Opportunities

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Forecast for the Controlled Release Drug Delivery Market Growth in 2025?

    In recent years, the market size for controlled release drug delivery has expanded swiftly. It is forecasted to rise from $65.44 billion in 2024 to $73.01 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%. The growth experienced in the historical period is linked to the amendment and advancement in drug delivery systems, the inception of early polymer-based formulations, the development and implementation of microencapsulation techniques, the transformation brought about by transdermal delivery, the acquisition of regulatory approvals, and the achievement of standardization.

    What Is the Forecast for the Controlled Release Drug Delivery Market Size Through 2029?

    In the coming years, the market size for controlled release drug delivery is projected to experience significant expansion, reaching a worth of $119.41 billion by 2029, with a compound annual growth rate (CAGR) of 13.1%. The forecasted growth during this period is because of several factors, such as the transition to personalized medicine, the incorporation of technology for patient ease, the growth of biologics and biosimilars, market growth in emerging regions, and progress in polymer science. Key trends to watch during the forecast period encompass biodegradable and biocompatible materials, the progress of nanotechnology, personalized and targeted medicine therapies, upgrades in implantable devices, and pioneering encapsulation methods.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp

    What are the Key Market Players in Controlled Release Drug Delivery Market and How They’re Evolving?

    Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.

    What Are the Primary Growth Drivers in the Controlled Release Drug Delivery Market?

    The increasing instances of chronic diseases are anticipated to drive the growth of the controlled release drug delivery market. These chronic conditions, also referred to as noncommunicable diseases, include ailments like heart disease, cancer, and diabetes that usually last more than a year, necessitate ongoing medical care, and may limit daily activities. The use of controlled-release drug delivery systems plays a vital role in chronic disease treatment. For chronic patients needing long-term treatment or those living in areas with limited healthcare resources and access, drug delivery systems that facilitate extended medication release are crucial. For example, the World Health Organization (WHO), a health-specialized agency based in Switzerland, reported in September 2022 that chronic diseases cause 41 million deaths annually, constituting 74 percent of all deaths worldwide. Chronic diseases result in the premature death of 17 million individuals before they reach 70 years of age, and 77 percent of these deaths occur in low- and middle-income countries. These numbers are predicted to increase in the future. Hence, the surging instances of chronic diseases are driving the expansion of the controlled release drug delivery market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=9930&type=smp

    What Are the Leading Segments in the Global Controlled Release Drug Delivery Industry?

    The controlled release drug delivery market covered in this report is segmented –

    1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies

    2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,

    3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications

    4) By End User: Hospitals, Clinics, Personal, Research, Other End Users

    Subsegments:

    1) By Wurster Technique: Spray Coating, Fluid Bed Coating

    2) By Coacervation: Simple Coacervation, Complex Coacervation

    3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation

    4) By Implants: Biodegradable Implants, Non-Biodegradable Implants

    5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems

    6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes

    7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems

    What Are the Key Market Trends in the Controlled Release Drug Delivery Industry?

    The rise of technological innovation is an emerging trend in the controlled-release drug delivery market. Major firms in this sector are embracing cutting-edge technologies to maintain market dominance. An example is Evonik Industries AG, a pharmaceutical company based in Germany, which launched UDRATEC SoluFlow in March 2022. This innovative microparticle technology has been developed to enhance the solubility of active ingredients in oral drug formulations. Unlike conventional production techniques, this emulsion-based process can overcome solidity challenges. EUDRATEC SoluFlow is part of Evonik Health Care’s portfolio of oral drug delivery systems, which feature oral excipients like EUDRAGIT functional polymers, ready-to-fill capsules such as EUDRACAPTM, and multiple other techniques and services to augment drug performance.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

    What Is the Regional Outlook for the Controlled Release Drug Delivery Market?

    North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9930

    This Report Delivers Insight On:

    1. How big is the controlled release drug delivery market, and how is it changing globally?

    2. Who are the major companies in the controlled release drug delivery market, and how are they performing?

    3. What are the key opportunities and risks in the controlled release drug delivery market right now?

    4. Which products or customer segments are growing the most in the controlled release drug delivery market?

    5. What factors are helping or slowing down the growth of the controlled release drug delivery market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 2071930708

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Controlled Release Drug Delivery Industry Growth Expected to Reach $119.41 Billion by 2029 at a CAGR of 13.1% | Segmentation and Growth Opportunities

    Controlled Release Drug Delivery Industry Growth Expected to Reach $119.41 Billion by 2029 at a CAGR of 13.1% | Segmentation and Growth Opportunities

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Forecast for the Controlled Release Drug Delivery Market Growth in 2025?

    In recent years, the market size for controlled release drug delivery has expanded swiftly. It is forecasted to rise from $65.44 billion in 2024 to $73.01 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%. The growth experienced in the historical period is linked to the amendment and advancement in drug delivery systems, the inception of early polymer-based formulations, the development and implementation of microencapsulation techniques, the transformation brought about by transdermal delivery, the acquisition of regulatory approvals, and the achievement of standardization.

    What Is the Forecast for the Controlled Release Drug Delivery Market Size Through 2029?

    In the coming years, the market size for controlled release drug delivery is projected to experience significant expansion, reaching a worth of $119.41 billion by 2029, with a compound annual growth rate (CAGR) of 13.1%. The forecasted growth during this period is because of several factors, such as the transition to personalized medicine, the incorporation of technology for patient ease, the growth of biologics and biosimilars, market growth in emerging regions, and progress in polymer science. Key trends to watch during the forecast period encompass biodegradable and biocompatible materials, the progress of nanotechnology, personalized and targeted medicine therapies, upgrades in implantable devices, and pioneering encapsulation methods.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp

    What are the Key Market Players in Controlled Release Drug Delivery Market and How They’re Evolving?

    Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.

    What Are the Primary Growth Drivers in the Controlled Release Drug Delivery Market?

    The increasing instances of chronic diseases are anticipated to drive the growth of the controlled release drug delivery market. These chronic conditions, also referred to as noncommunicable diseases, include ailments like heart disease, cancer, and diabetes that usually last more than a year, necessitate ongoing medical care, and may limit daily activities. The use of controlled-release drug delivery systems plays a vital role in chronic disease treatment. For chronic patients needing long-term treatment or those living in areas with limited healthcare resources and access, drug delivery systems that facilitate extended medication release are crucial. For example, the World Health Organization (WHO), a health-specialized agency based in Switzerland, reported in September 2022 that chronic diseases cause 41 million deaths annually, constituting 74 percent of all deaths worldwide. Chronic diseases result in the premature death of 17 million individuals before they reach 70 years of age, and 77 percent of these deaths occur in low- and middle-income countries. These numbers are predicted to increase in the future. Hence, the surging instances of chronic diseases are driving the expansion of the controlled release drug delivery market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=9930&type=smp

    What Are the Leading Segments in the Global Controlled Release Drug Delivery Industry?

    The controlled release drug delivery market covered in this report is segmented –

    1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies

    2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,

    3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications

    4) By End User: Hospitals, Clinics, Personal, Research, Other End Users

    Subsegments:

    1) By Wurster Technique: Spray Coating, Fluid Bed Coating

    2) By Coacervation: Simple Coacervation, Complex Coacervation

    3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation

    4) By Implants: Biodegradable Implants, Non-Biodegradable Implants

    5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems

    6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes

    7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems

    What Are the Key Market Trends in the Controlled Release Drug Delivery Industry?

    The rise of technological innovation is an emerging trend in the controlled-release drug delivery market. Major firms in this sector are embracing cutting-edge technologies to maintain market dominance. An example is Evonik Industries AG, a pharmaceutical company based in Germany, which launched UDRATEC SoluFlow in March 2022. This innovative microparticle technology has been developed to enhance the solubility of active ingredients in oral drug formulations. Unlike conventional production techniques, this emulsion-based process can overcome solidity challenges. EUDRATEC SoluFlow is part of Evonik Health Care’s portfolio of oral drug delivery systems, which feature oral excipients like EUDRAGIT functional polymers, ready-to-fill capsules such as EUDRACAPTM, and multiple other techniques and services to augment drug performance.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

    What Is the Regional Outlook for the Controlled Release Drug Delivery Market?

    North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9930

    This Report Delivers Insight On:

    1. How big is the controlled release drug delivery market, and how is it changing globally?

    2. Who are the major companies in the controlled release drug delivery market, and how are they performing?

    3. What are the key opportunities and risks in the controlled release drug delivery market right now?

    4. Which products or customer segments are growing the most in the controlled release drug delivery market?

    5. What factors are helping or slowing down the growth of the controlled release drug delivery market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Emerging Growth Drivers in the Controlled Release Drug Delivery Market Landscape: Controlled-Release Drug Delivery Market Surges As Chronic Diseases Become Global Health Priority

    Discover trends, market shifts, and competitive outlooks for the controlled release drug delivery industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    How Fast Is The Controlled Release Drug Delivery Market Expected to Grow Between 2025 And 2029?

    The market size for controlled release drug delivery has experienced swift expansion in prior years. The market value is set to increase from $65.44 billion in 2024 to $73.01 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.6%. This significant growth during the historic period can be credited to the development of innovative drug delivery systems, the inception of polymer-based formulations, the implementation of microencapsulation techniques, the advent of transdermal delivery, regulatory consent, and standardization processes.

    In the coming years, the controlled release drug delivery market is predicted to experience significant expansion. The market is projected to reach $119.41 billion in 2029 with a compound annual growth rate (CAGR) of 13.1%. This expected growth in the forecast period is due to several factors such as the shift towards personalized medicine, the integration of technology to enhance patient comfort, the broadening scope of biologics and biosimilars, market growth in emerging regions, and advances in polymer science. The forecast period will be characterized by major trends including the use of biodegradable and biocompatible materials, advancements in nanotechnology, personalized medicine and targeted therapies, development in implantable devices, and innovative encapsulation methods.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp

    Which Primay Drivers Are Accelerating Growth in the Controlled Release Drug Delivery Market?

    The growing incidence of long-term ailments is anticipated to drive the controlled release drug delivery market’s expansion. Chronic diseases, also known as noncommunicable diseases include conditions like heart disease, cancer, and diabetes that last more than a year and need ongoing medical attention, restrict daily activities, or both. The critical role of controlled-release drug delivery for these illnesses cannot be overstated. It’s particularly important for individuals suffering from long-term illnesses that require extended treatment periods or those who live in regions with restricted resources and healthcare accessibility. Formulations that enable extended medication release are vital for these regions. For example, in September 2022, a report from the Switzerland-based World Health Organization highlighted that every year, 41 million people dying from chronic diseases account for 74 percent of worldwide fatalities. 17 million people succumb before reaching the age of 70, and 77 percent of these deaths occur in low-middle income countries. Predictions suggest these figures will continue to climb, emphasizing how the controlled release drug delivery market’s growth is driven by the increasing prevalence of chronic diseases.

    Which Primary Segments of the Controlled Release Drug Delivery Market Are Driving Growth and Industry Transformations?

    The controlled release drug delivery market covered in this report is segmented –

    1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies

    2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,

    3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications

    4) By End User: Hospitals, Clinics, Personal, Research, Other End Users

    Subsegments:

    1) By Wurster Technique: Spray Coating, Fluid Bed Coating

    2) By Coacervation: Simple Coacervation, Complex Coacervation

    3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation

    4) By Implants: Biodegradable Implants, Non-Biodegradable Implants

    5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems

    6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes

    7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=9930&type=smp

    Which Regions Are Key Players in the Growth of the Controlled Release Drug Delivery Market?

    North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Which Technological Trends Are Reshaping the Controlled Release Drug Delivery Industry Dynamics?

    The rapid progression of technology is a predominant trend making headway in the controlled-release drug delivery market. In order to remain competitive, leading businesses in this market are opting for innovative technology. In March 2022, Evonik Industries AG, a pharmaceutical company based in Germany, introduced its latest innovation, UDRATEC SoluFlow – a new microparticle mechanism set to enhance the solubility of active medical ingredients in oral drug compositions. This method of emulsion resolves solubility challenges that cannot be tackled by conventional production procedures. The addition of EUDRATEC SoluFlow to Evonik Health Care’s repertoire of oral drug system solutions, such as oral excipients like EUDRAGIT functional polymers, ready-to-fill functional capsules like EUDRACAP™, and an array of other technologies and services, aims to elevate the efficacy of medications.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

    What Parameters Are Used to Define the Controlled Release Drug Delivery Market?

    Controlled release drug delivery refers to a dosage form that administers a medicine or medication in a specified way. This drug delivery method continuously delivers pharmaceuticals or medications in predictable kinetics for the predetermined time.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9930

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Controlled Release Drug Delivery Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

    Controlled Release Drug Delivery Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Are the Primary Drivers Supporting the Market Growth of theControlled Release Drug Delivery Market?

    The increasing occurrence of long-term diseases is predicted to boost the expansion of the controlled release drug delivery market. These chronic diseases, also recognized as noncommunicable diseases, predominantly include heart disease, cancer, and diabetes that continue for more than a year, requiring ongoing medical attention or restricting regular activities, or both. The role of controlled-release drug delivery treatments is pivotal in combating these diseases. Such delivery systems are invaluable for patients suffering from chronic illnesses that need prolonged treatment, or for those living in areas with scarce resources and medical facilities, as these systems ensure extended release of medication. For example, a report by the World Health Organization (WHO), a health-focused agency based in Switzerland, revealed in September 2022 that every year, chronic diseases claim 41 million lives, making up 74 percent of all global deaths. Chronic illnesses cause 17 million premature deaths before the age of 70. Furthermore, it was observed that 77 percent of these deaths occur in low- to middle-income countries. With these figures projected to escalate in the future, the growing incidence of chronic diseases is indeed fueling the advancement of the controlled release drug delivery market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp

    #What Growth Opportunities Will Drive the Controlled Release Drug Delivery Market’s CAGR Through 2034?

    The market for controlled release drug delivery has experienced rapid expansion in the past few years. A growth from $65.44 billion in 2024 to $73.01 billion in 2025 is projected, which reflects an 11.6% compound annual growth rate (CAGR). Groundbreaking drug delivery systems, prior polymer-based preparations, the advent of microencapsulation methods, the rise of transdermal delivery, regulatory accreditations, and standardization have all contributed to the advancement during the historic period.

    The market for controlled release drug delivery is anticipated to experience substantial growth in the coming years, swelling to an impressive $119.41 billion by 2029, reflecting a compound annual growth rate (CAGR) of 13.1%. This growth in the projected timeline is linked to the shift towards personalized medicine, incorporation of technology for the benefit of patient convenience, growth of biologics and biosimilars, market progression in emerging regions and advancements in the field of polymer science. Noteworthy trends during this forecast period include materials that are both biodegradable and biocompatible, advancements in nanotechnology, increased emphasis on personalized medicine and targeted therapies, developments in implantable devices, and innovative encapsulation methods.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9930

    What Are the Latest Innovations Influencing theControlled Release Drug Delivery Market?

    The uptake of innovative technologies is a crucial trend being observed in the controlled-release drug delivery market. In an effort to consolidate their market standing, principal companies in this sector are embracing these new advancements. For example, Evonik Industries AG, a pharmaceutical company based in Germany, unveiled UDRATEC SoluFlow in March 2022. UDRATEC SoluFlow is an innovative microparticle technology that enhances the solubility of active components in oral drugs. This technique, based on an emulsion process, can surmount the solubility challenges that conventional production methods fail to address. In addition to UDRATEC SoluFlow, Evonik Health Care offers a plethora of oral drug delivery solutions, including oral excipients like EUDRAGIT functional polymers, EUDRACAPTM ready-to-fill functional capsules, and a range of other technologies and services that enhance medicine efficacy.

    Who Are the Major Industry Players Accelerating Growth in theControlled Release Drug Delivery Market?

    Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

    Which Primary Segments of the Controlled Release Drug Delivery Market Are Driving Growth and Industry Transformations?

    The controlled release drug delivery market covered in this report is segmented –

    1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies

    2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,

    3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications

    4) By End User: Hospitals, Clinics, Personal, Research, Other End Users

    Subsegments:

    1) By Wurster Technique: Spray Coating, Fluid Bed Coating

    2) By Coacervation: Simple Coacervation, Complex Coacervation

    3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation

    4) By Implants: Biodegradable Implants, Non-Biodegradable Implants

    5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems

    6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes

    7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=9930&type=smpGlobal Controlled Release Drug Delivery Market, Global Controlled Release Drug Delivery Market Report, Global Controlled Release Drug Delivery Market Trends, Global Controlled Release Drug Delivery Market Size

    Browse Through More Reports Similar to the Gobal Controlled Release Drug Delivery Maret 2025, By The Business Research Company:

    Drugs For Erectile Dysfunction Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drugs-for-erectile-dysfunction-global-market-report

    Drugs For Hormonal Replacement Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

    Drug Delivery Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • How is the Controlled Release Drug Delivery Market Poised for Growth: Trends and Opportunities Through 2034

    How is the Controlled Release Drug Delivery Market Poised for Growth: Trends and Opportunities Through 2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What fueled the previous growth in the controlled release drug delivery market?

    The market size of controlled release drug delivery has seen a swift expansion in the past years. The market worth is predicted to rise from $65.44 billion in 2024 to $73.01 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%. This substantial growth experienced during the historical period is linked to the advent of innovative drug delivery systems, initial polymer-based formulations, the introduction of microencapsulation techniques, the rise of transdermal delivery, regulatory authorizations, and standardization.

    What will be the controlled release drug delivery market size in the future?

    In the coming years, the controlled release drug delivery market is projected to experience significant growth. It is anticipated to reach a value of $119.41 billion in 2029, with a CAGR of 13.1%. Factors that are likely to contribute to this growth during the forecast period include a shift towards personalized medicine, patient-friendly technology integration, growth of biologics and biosimilars, market expansion in emerging regions, and advances in polymer science. Key trends to watch out for in this period involve biodegradable and biocompatible materials, developments in nanotechnology, personalized and targeted treatments, enhancements in implantable devices, and creative encapsulation techniques.

    Get your controlled release drug delivery market report here!

    https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

    What main drivers are fueling expansion in the controlled release drug delivery market?

    The growth of the controlled release drug delivery market is projected to be accelerated by the increasing occurrences of chronic diseases. These long-term illnesses, also known as noncommunicable diseases, such as heart disease, diabetes, and cancer, necessitate ongoing medical care and may restrict daily activities. Delivering drugs in a controlled-release manner is essential for managing these persistent diseases. Prolonged medication release formulations are vital for those living with chronic conditions that demand years of treatment or for those in locations with restricted healthcare resources and access. For instance, a report from the World Health Organization (WHO), a Switzerland-based health-specialized agency, in September 2022, revealed that chronic diseases account for 74 percent of worldwide deaths, totaling 41 million lives lost each year. 17 million of these deaths occur before the age of 70, and 77 percent of chronic disease deaths happen in low- to middle-income countries. Projections indicate that these statistics may increase in the future. As a result of these trends, the controlled release drug delivery market is experiencing significant growth driven by an escalating prevalence of chronic diseases.

    What key areas define the segmentation of the global controlled release drug delivery market?

    The controlled release drug delivery market covered in this report is segmented –

    1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies

    2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,

    3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications

    4) By End User: Hospitals, Clinics, Personal, Research, Other End Users

    Subsegments:

    1) By Wurster Technique: Spray Coating, Fluid Bed Coating

    2) By Coacervation: Simple Coacervation, Complex Coacervation

    3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation

    4) By Implants: Biodegradable Implants, Non-Biodegradable Implants

    5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems

    6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes

    7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp

    Who are the dominant players expanding their reach in the controlled release drug delivery market?

    Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.

    How are evolving market trends shaping controlled release drug delivery Strategies?

    The controlled-release drug delivery market is increasingly embracing technological advancements as a key trend. To maintain their market positions, leading companies in this sector are adopting cutting-edge technologies. A case in point is Evonik Industries AG, a pharmaceutical company based in Germany, which introduced UDRATEC SoluFlow in March 2022. UDRATEC SoluFlow, a revolutionary microparticle technology, enhances the solubility of active ingredients in oral drugs. Unlike traditional production methods, this emulsion-based process technique is capable of overcoming solubility challenges. The addition of EUDRATEC SoluFlow has expanded Evonik Health Care’s collection of oral drug delivery solutions, which encompasses oral excipients like EUDRAGIT functional polymers, pre-filled functional capsules such as EUDRACAPTM, and a range of other techniques and services designed to enhance drug performance.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9930

    Which regions are emerging as leaders in the controlled release drug delivery market?

    North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Similar Reports By The Business Research Company:

    Drugs For Erectile Dysfunction Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drugs-for-erectile-dysfunction-global-market-report

    Drugs For Hormonal Replacement Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

    Drug Delivery Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • How Will the Controlled Release Drug Delivery Market Grow? Key Trends and Opportunities for 2025 and Beyond

    How Will the Controlled Release Drug Delivery Market Grow? Key Trends and Opportunities for 2025 and Beyond

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How Will the Controlled Release Drug Delivery Market Grow Over the Forecast Period Based on Its Expected CAGR?

    The market size of the controlled release drug delivery has seen significant expansion in the preceding years. The market, which was valued at $65.44 billion in 2024, is predicted to swell to $73.01 billion in 2025, displaying a compound annual growth rate (CAGR) of 11.6%. The notable growth witnessed in the past period can be linked to the advent of innovative drug delivery systems, initial polymer-based recipes, the introduction of microencapsulation processes, the rise of transdermal delivery, the granting of regulatory permits, and standardization efforts.

    The market size of controlled release drug delivery is predicted to undergo swift expansion in the forthcoming years. The growth is projected to hit $119.41 billion in 2029, with a compound annual growth rate (CAGR) of 13.1%. Factors contributing to this growth during the forecast period include the movement towards personalized medicine, the assimilation of technology for the benefit of patients, the broadening scope of biologics and biosimilars, market stretching in emerging regions, and polymer science advancements. Significant trends in the forecast timeframe are likely to encompass degradable and compatible materials, progress in nanotechnology, personalized medicine & targeted therapies, improvements in implantable devices, and innovative methods of encapsulation.

    What Factors Are Propelling the Growth of the controlled release drug delivery Market from 2025 to 2034?

    The increasing occurrence of chronic or noncommunicable afflictions such as heart disease, cancer, and diabetes is believed to drive the expansion of the controlled release drug delivery market. These are health conditions that persist over a year, necessitate ongoing medical attention, and often impose limitations on an individual’s routine activities. The role of controlled-release drug delivery is pivotal for the effective treatment of these illnesses. For patients suffering from chronic diseases needing long-term care, or those living in areas with inadequate healthcare facilities, medication delivery methods facilitating prolonged release of drugs are indispensable. As per a report in September 2022 by the World Health Organization (WHO), a health-specialized entity based in Switzerland, chronic diseases claim the lives of 41 million individuals annually, making up 74% of all global deaths. Tragically, 17 million people succumb to such health problems before they reach their seventieth birthday. Alarmingly, most of these deaths, 77% to be precise, take place in low-income and middle-income countries. The statistics are anticipated to surge in the future. Consequently, the increasing prevalence of chronic diseases is fuelling the growth of the controlled release drug delivery market.

    Explore Comprehensive Insights Into The Global Controlled Release Drug Delivery Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp

    Who Are the Dominant Players Expanding Their Reach in the Controlled Release Drug Delivery Market?

    Major companies operating in the controlled release drug delivery market include:

    • Johnson & Johnson Services Inc._x000D_

    • Merck & Co. Inc._x000D_

    • Alkermes plc_x000D_

    • Coating Place Inc._x000D_

    • Corium International Inc._x000D_

    What Are the Top Trends Shaping the Evolution of the Controlled Release Drug Delivery Market?

    In the controlled-release drug delivery market, one significant trend that is increasingly being observed is the technological evolution. To retain their market positions, large firms in this field are embracing innovative technologies. For instance, in March 2022, a pharmaceutical company based in Germany, Evonik Industries AG, unveiled a revolutionary microparticle technology, UDRATEC SoluFlow, aimed at augmenting the solubility of active medicinal ingredients in orally administered drugs. This technique of emulsion-based processing surpasses solubility issues that conventional manufacturing methods fail to overcome. Adding to their suite of oral drug delivery solutions, EUDRATEC SoluFlow complements Evonik Health Care’s product lineup which features oral excipients such as EUDRAGIT functional polymers, pre-ready functional capsules like EUDRACAPTM, and more technologies and services to enhance medication effectiveness.

    Secure Your Global Controlled Release Drug Delivery Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

    Which Market Segments Are Driving Strategic Growth and Trends in the Controlled Release Drug Delivery Market?

    The controlled release drug delivery market covered in this report is segmented –

    1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies

    2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,

    3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications

    4) By End User: Hospitals, Clinics, Personal, Research, Other End Users

    Subsegments:

    1) By Wurster Technique: Spray Coating, Fluid Bed Coating

    2) By Coacervation: Simple Coacervation, Complex Coacervation

    3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation

    4) By Implants: Biodegradable Implants, Non-Biodegradable Implants

    5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems

    6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes

    7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems

    Which Regions Are Setting the Pace for Controlled Release Drug Delivery Market Growth?

    North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    How Is the Controlled Release Drug Delivery Market Defined Across Different Regions?

    Controlled release drug delivery refers to a dosage form that administers a medicine or medication in a specified way. This drug delivery method continuously delivers pharmaceuticals or medications in predictable kinetics for the predetermined time.

    Browse Through More Similar Reports By The Business Research Company:

    Drugs For Erectile Dysfunction Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drugs-for-erectile-dysfunction-global-market-report

    Drugs For Hormonal Replacement Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

    Drug Delivery Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • In-Depth 2024 Controlled Release Drug Delivery Market Analysis: Growth, Share, and Emerging Trends

    In-Depth 2024 Controlled Release Drug Delivery Market Analysis: Growth, Share, and Emerging Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    2024-2033 Controlled Release Drug Delivery Market Growth Rate: What’s the Forecast?

    The market size of controlled release drug delivery has experienced quick expansion in the past few years. The market value is projected to rise from $59.2 billion in 2023, and hit $66.18 billion in 2024, demonstrating a compound annual growth rate (CAGR) of 11.8%. The unprecedented growth during the historic period is a result of groundbreaking drug delivery systems, advent of early polymer-based formulations, the application of microencapsulation techniques, the development of transdermal delivery, along with regulatory approvals and standardization.

    In the coming years, the controlled release drug delivery market is anticipated to witness a steep rise in its size. The market value is projected to surge to $105.06 billion in 2028, recording a compound annual growth rate (CAGR) of 12.2%. The growth trajectory during the forecast period is largely ascribed to factors such as a shift towards personalized medicine, fusion of technology for patient comfort, proliferation of biologics and biosimilars, market breakthrough in developing regions, and strides in polymer science. During the forecast period, significant trends encompass the development of biodegradable and biocompatible materials, progress in nanotechnology, personalized medicine and targeted therapies, advancements in implantable devices, and innovative encapsulation methods.

    Claim Your Free Sample of the Global Controlled Release Drug Delivery Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp

    What Drivers Are Accelerating the Growth of the controlled release drug delivery Market?

    Expectations are that the escalating incidence of chronic conditions will fuel the expansion of the controlled release drug delivery market. Chronic conditions, also classified as noncommunicable diseases, are represented by health issues such as heart disease, cancer, and diabetes—ailments that extend beyond a year, demand constant medical attention, and potentially hamper ordinary activities. Controlled-release drug delivery methods are essential in addressing these persistent diseases. For patients suffering from long-standing ailments requiring extended treatment periods or for those living in locations where healthcare resources and accessibility are inadequate, drug delivery designs that facilitate extended medication release are key. As per a report published by the World Health Organization (WHO), a Switzerland-based health-specialized institution, in September 2022, about 41 million individuals succumb to chronic diseases each year, accounting for 74 percent of all global deaths. Chronic diseases claim the lives of 17 million people prior to the age of 70. Furthermore, 77 percent of chronic disease-induced deaths take place in low to middle-income countries. These figures are projected to escalate in time. Hence, the controlled release drug delivery market growth is being driven by the increasing presence of chronic diseases.

    What Key Segments Can Be Identified in the Controlled Release Drug Delivery Market?

    1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies

    2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,

    3) By Application: Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches, Other Applications

    4) By End User: Hospitals, Clinics, Personal, Research, Other End Users

    What Trends Are On the Rise in the Controlled Release Drug Delivery Market?

    Emerging technologies are setting the pace in the controlled-release drug delivery market, rising as the prevailing trend. To safeguard their standing in the market, dominant companies have begun embracing these new advancements. For instance, Evonik Industries AG, a pharmaceutical firm rooted in Germany, introduced UDRATEC SoluFlow in March 2022. This novel microparticle technology innovation is designed to enhance the solubility of active medicinal components in pills. The technique is an emulsion-based process that surpasses the existing production methods’ limitations on solubility. UDRATEC SoluFlow is a valuable addition to Evonik Health Care’s collection of oral drug delivery systems, involving oral excipients like EUDRAGIT functional polymers, ready-to-fill functional capsules including EUDRACAPTM, and additional techniques and services to refine medication efficacy.

    Order Now for Fast Delivery of Your Controlled Release Drug Delivery Market Report!

    https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

    What Regions Are Steering Growth in the Controlled Release Drug Delivery Sector?

    North America was the largest region in the controlled release drug delivery market in 2023. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Controlled Release Drug Delivery Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the controlled release drug delivery market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Controlled Release Drug Delivery Market Include

    1. Controlled Release Drug Delivery Market Executive Summary

    2. Controlled Release Drug Delivery Market Segments

    3. Controlled Release Drug Delivery Market Size And Template Market Growth Rate

    4. Key Controlled Release Drug Delivery Market Trends

    5. Major Controlled Release Drug Delivery Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Controlled Release Drug Delivery Market

    26. Top Controlled Release Drug Delivery Companies

    27. Controlled Release Drug Delivery Market Opportunities And Strategies

    28. Controlled Release Drug Delivery Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Controlled Release Drug Delivery Global Market Outlook 2024-2033: Size And Growth Rate Analysis

    Controlled Release Drug Delivery Global Market Outlook 2024-2033: Size And Growth Rate Analysis

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    the controlled-release drug delivery market has witnessed substantial growth, driven by various factors contributing to its expansion and development. Let’s explore the trends, drivers, and dynamics shaping this thriving sector.

    1. Understanding Market Growth
    • The controlled release drug delivery market has experienced rapid expansion, with its size reaching $59.2 billion in 2023 and projected to grow to $66.18 billion in 2024, at a remarkable CAGR of 11.8%.
    • Pioneering drug delivery systems, early polymer-based formulations, and microencapsulation techniques have fueled growth in the historic period.
    1. Anticipated Growth Trajectory
    • Forecasts indicate continued rapid growth, with the market expected to reach $105.06 billion by 2028, showcasing a CAGR of 12.2%.
    • Factors driving growth include the shift towards personalized medicine, technological integration for patient convenience, and expansion of biologics and biosimilars.
    1. Addressing the Rise in Chronic Diseases
    • The prevalence of chronic diseases, such as heart disease, cancer, and diabetes, has surged globally, making them a top priority in healthcare.
    • Controlled-release drug delivery plays a crucial role in managing chronic conditions by providing sustained medication release, especially for patients with limited access to healthcare resources.

    View More On The Controlled Release Drug Delivery Market Report 2024 – https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

    1. Technological Advancements
    • Technological innovations are reshaping the landscape of controlled-release drug delivery, with companies investing in advanced solutions to enhance drug efficacy and patient outcomes.
    • Groundbreaking technologies like microparticle technology are revolutionizing drug delivery systems, improving solubility and overall medication performance.
    1. Strategic Acquisitions Driving Market Expansion
    • Strategic acquisitions, such as Alcon’s acquisition of Aerie Pharmaceuticals, Inc., underscore the industry’s focus on portfolio expansion and market consolidation.
    • Expansion into complementary areas enhances companies’ product offerings and strengthens their competitive position.
    1. Segment Analysis
    • The controlled-release drug delivery market is segmented by technology, release mechanism, application, and end-user.
    • Segmentation allows for targeted approaches in product development and marketing strategies, catering to diverse consumer needs and preferences.
    1. Regional Dominance
    • North America emerges as the largest region in the controlled-release drug delivery market, reflecting its advanced healthcare infrastructure and significant investments in research and development.
    • The region’s dominance underscores its pivotal role in driving industry growth and innovation.

    In conclusion, the controlled-release drug delivery market continues to thrive, propelled by advancements in technology, increasing demand for personalized medicine, and the rise in chronic diseases worldwide. Strategic initiatives, such as acquisitions and investments in research and development, are reshaping the competitive landscape and driving market expansion. As the market evolves, stakeholders must adapt to emerging trends and consumer needs to capitalize on growth opportunities and deliver impactful solutions that enhance patient care and outcomes globally.

    Request A Sample Of The Global Controlled Release Drug Delivery Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9930&type=smp